Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
The present invention provides novel compounds of formula (I) and their use in the inhibition of c-Jun N-terminal kinases. The present invention further provides the use of these compounds in medicine, in particular in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation.
patent: 5714495 (1998-02-01), Viaud et al.
patent: 2002/0013354 (2002-01-01), Cheng et al.
patent: 98/47899 (1998-10-01), None
patent: WO-98/47899 (1998-10-01), None
patent: WO-99/21859 (1999-05-01), None
patent: WO-99/51233 (1999-10-01), None
patent: WO-00/43393 (2000-07-01), None
patent: WO-01/49288 (2001-07-01), None
patent: WO-03/028724 (2003-04-01), None
patent: WO-03/082868 (2003-10-01), None
patent: WO-03/082869 (2003-10-01), None
patent: WO-2004/016609 (2004-02-01), None
patent: WO-2004/016610 (2004-02-01), None
Tamao et al., “Palladium-Catalyzed Cross-Coupling REaction of Alkenylalkosysilanes with Aryl and Alkenyl Halides in the Presence of a Fluoride Ion”Tetrahedron Letters, vol. 30, No. 44 pp. 6051-6054 (1989).
Stille, J.K., “The Palladium-Catalyzed Cross-Coupling Reactions of Organotin REagents with Organic Electrophiles”Angew. Chem. Int. Ed. Engl. 25 pp. 508-524 (1986).
Hatanaka et al., “Cross-Coupling of Organosilanes with Organic Halides Mediated by Palladium Catalyst and Tris(diethylamino)sulfonium Difluorotrimethylsilicate”J. Org. Chem53 pp. 918-920 (1988).
Littke et al., “Pd/P(t-Bu)3: A Mild and General Catalyst for Stille Reactions of Aryl Chlorides and Aryl Bromides”J. Am. Chem. Soc. 124 pp. 6343-6348 (2002).
Hatanaka et al., “Highly Selective Cross-Coupling Reactions of Organosilicon Compounds Mediated by Fluoride Ion and a Palladium Catalyst”,Synlettpp. 845-853 (1991).
Littke et al., “Versatile Catalysts for the Suzuki Cross-Coupling of Arylboronic Acids with Aryl and Vinyl Halides and Triflates under Mild Conditions”J. Am. Chem. Soc. 122 pp. 4020-4028 (2000).
Denmark et al., “Highly Stereospecific, Palladium-Catalyzed Cross-Coupling of Alkenylsilanols”Organic Lettersvol. 2, No. 4, pp. 565-568 (2000).
Suzuki, A. “Synthetic Studies via the Cross-Coupling REaction of Organoboron Derivatives with Organic Halides”Pure Appl. Chemvol. 63, No. 3 pp. 419-422 (1991).
Mitchell, T. “Palladium-Catalysed Reactions of Organotin Compounds”Synthesispp. 803-815 (1992).
Denmark et al., “Convergence of Mechanistic Pathways in the Palladium(0)-Catalyzed Cross-Coupling of Alkenylsilacyclobutanes and Alkenylsilanols”Organic Letters. vol. 2, No. 16, pp. 2491-2494. (2000).
Corey, E.Jr., et. al.., A synthetic Method for Formyl-Ethynyl Conversion (RCHO-RC=CH or RC=CR′), Tetrahedron Letters No. 36, (Aug. 1972).
Dhar, et al., “The TosMIC Approach to 3-(Oxazol-5-yl) Indoles: Application to the Synthesis of Indole-Based IMPDH Inhibitors,” Bioorganic & Medicinal Chemistry Letters, (2002).
Houwing, et al., Preparation of N-Tosylmethylimino Compounds and their Use in the Synthesis of Oxazoles, Imidazoles and Pyrroles, Tetrahedron Letters No. 2, (1976).
Van Leusen, et al., Chapter 3: Synthetic Uses of Tosylmethyl Isocyanide (TosMIC), Organic Reactions, vol. 57, (2001).
Guillard, et al. “Synthesis of New Maltonin Analogues from Dimers of Azaindole and Indole by Use of Suzuki Monocoupling”, Heterocycles, vol. 60, No. 4, pp. 865-877 (2003).
Database Beilstein, Beilstein Institute for Organic Chemistry, Citation No. 5563002 (1987).
Mettey, et al., “Aloisines, a New Family of CDK/GSK-3 Inhibitors. SAR STudy, Crystal Structure in Complex with CDK2, Enzyme Selectivity and Cellular Effects”, J. Med. Chem, 46, pp. 222-236 (2003).
Pisano et al, “Bis-indols: a Novel Class of Molecules Enhancing the Cytodifferentiating Properties of Retinoids in Myeloid Leukemia Cells”, Blood, vol. 100, No. 10 (2002).
Harper, et al., “Inhibitors of the JNK Sinaling Pathway”, Drugs of the Future, vol. 26, No. 10 (2001).
Kumar et al, “Synthesis of 7-Azaindole and 7-Azaoxindole Derivatives through a Palladium-Catalyzed Cross Coupling Reaction”, J. Org. Chem, 57, pp. 6995-6998 (1992).
Witherington et al., “5-Aryl-pyrazolo [3,4-b]pyridines: Potent Inhibitors of Glycogen Synthase Kinase-3 (GSK-3)”, Bioorganic & Medicinal Chemistry Letters 13, pp. 1577-1580 (2003).
Park et al, “A FAcile Synthesis of 2,3-Disubstitute Pyrrolo[2,3-b]pyridines via Palladium-Catalyzed Heteroannulation with Internal Alkynes”, Tetrahedron Letters 39, pp. 627-630 (1998).
Eisai R & D Management Co. Ltd.
Seaman D. Margaret
Wilmer Cutler Pickering Hale & Dorr LLP.
JNK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with JNK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and JNK inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990168